|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Garcia-Murillas I, Schiavon G, Weigelt B,
Ng C, Hrebien S, Cutts RJ, Cheang M, Osin P, Nerurkar A, Kozarewa
I, et al: Mutation tracking in circulating tumor DNA predicts
relapse in early breast cancer. Sci Transl Med. 7:302ra1332015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Im NK, Jang WJ, Jeong CH and Jeong GS:
Delphinidin suppresses PMA-induced MMP-9 expression by blocking the
NF-κB activation through MAPK signaling pathways in MCF-7 human
breast carcinoma cells. J Med Food. 17:855–861. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shalaby MA, Nounou HA, Ms AOA, Azzam N and
Saeed HM: Associations between single nucleotide polymorphisms of
COX-2 and MMP-2 genes and colorectal cancer susceptibility in the
Saudi population. Asian Pac J Cancer Prev. 15:4989–4994. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou R, Xu L, Ye M, Liao M, Du H and Chen
H: Formononetin inhibits migration and invasion of MDA-MB-231 and
4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through
PI3K/AKT signaling pathways. Horm Metab Res. 46:753–760. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Starr R, Willson TA, Viney EM, Murray LJ,
Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola
NA, et al: A family of cytokine-inducible inhibitors of signalling.
Nature. 387:917–921. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yoshimura A, Naka T and Kubo M: SOCS
proteins, cytokine signalling and immune regulation. Nat Rev
Immunol. 7:454–465. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Endo TA, Masuhara M, Yokouchi M, Suzuki R,
Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H,
et al: A new protein containing an SH2 domain that inhibits JAK
kinases. Nature. 387:921–924. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Senft C, Priester M, Polacin M, Schröder
K, Seifert V, Kögel D and Weissenberger J: Inhibition of the
JAK-2/STAT3 signaling pathway impedes the migratory and invasive
potential of human glioblastoma cells. J Neurooncol. 101:393–403.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miyoshi H, Fujie H, Moriya K, Shintani Y,
Tsutsumi T, Makuuchi M, Kimura S and Koike K: Methylation status of
suppressor of cytokine signaling-1 gene in hepatocellular
carcinoma. J Gastroenterol. 39:563–569. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hussain S, Singh N, Salam I, Bandil K,
Yuvaraj M, Bhat Akbar M, Mir Muzaffar M, Siddiqi MA, Sobti RC,
Bharadwaj M, et al: Methylation-mediated gene silencing of
suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal
squamous cell carcinoma patients of Kashmir valley. J Recept Signal
Transduct Res. 31:147–156. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Neuwirt H, Puhr M, Santer FR, Susani M,
Doppler W, Marcias G, Rauch V, Brugger M, Hobisch A, Kenner L, et
al: Suppressor of cytokine signaling (SOCS)-1 is expressed in human
prostate cancer and exerts growth-inhibitory function through
down-regulation of cyclins and cyclin-dependent kinases. Am J
Pathol. 174:1921–1930. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chu PY, Yeh CM, Hsu NC, Chang YS, Chang JG
and Yeh KT: Epigenetic alteration of the SOCS1 gene in
hepatocellular carcinoma. Swiss Med Wkly. 140:w130652010.PubMed/NCBI
|
|
14
|
Huang S, Chen J and Jia Y: Research on the
correlation of MMP9 and p53 expression with the prognosis of triple
negative breast cancer. Xiandai Shengwu Yixue Jinzhan. 14:881–884.
2014.
|
|
15
|
Choi JS, Baek HM, Kim S, Kim MJ, Youk JH,
Moon HJ, Kim EK and Nam YK: Magnetic resonance metabolic profiling
of breast cancer tissue obtained with core needle biopsy for
predicting pathologic response to neoadjuvant chemotherapy. PLoS
One. 8:e838662013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yari K and Rahimi Z, Moradi MT and Rahimi
Z: The MMP-2 −735 C allele is a risk factor for susceptibility to
breast cancer. Asian Pac J Cancer Prev. 15:6199–6203. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lamps LW and Folpe AL: The diagnostic
value of hepatocyte paraffin antibody 1 in differentiating
hepatocellular neoplasms from nonhepatic tumors: A review. Adv Anat
Pathol. 10:39–43. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kershaw NJ, Murphy JM, Liau NP, Varghese
LN, Laktyushin A, Whitlock EL, Lucet IS, Nicola NA and Babon JJ:
SOCS3 binds specific receptor-JAK complexes to control cytokine
signaling by direct kinase inhibition. Nat Struct Mol Biol.
20:469–476. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weissenberger J, Priester M, Bernreuther
C, Rakel S, Glatzel M, Seifert V and Kögel D: Dietary curcumin
attenuates glioma growth in a syngeneic mouse model by inhibition
of the JAK1,2/STAT3 signaling pathway. Clin Cancer Res.
16:5781–5795. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu TC, Lin SF, Chang JG, Yang MY, Hung SY
and Chang CS: Epigenetic alteration of the SOCS1 gene in chronic
myeloid leukaemia. Br J Haematol. 123:654–661. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stanganelli C, Arbelbide J, Fantl DB,
Corrado C and Slavutsky I: DNA methylation analysis of tumor
suppressor genes in monoclonal gammopathy of undetermined
significance. Ann Hematol. 89:191–199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Watanabe D, Ezoe S, Fujimoto M, Kimura A,
Saito Y, Nagai H, Tachibana I, Matsumura I, Tanaka T, Kanegane H,
et al: Suppressor of cytokine signalling-1 gene silencing in acute
myeloid leukaemia and human haematopoietic cell lines. Br J
Haematol. 126:726–735. 2004. View Article : Google Scholar : PubMed/NCBI
|
